Answers are grounded in this paper and cite their sources.
Cognitive impairment in depressive disorders may be associated with peripheral hematological and metabolic alterations, yet potential age-related differences remain insufficiently characterized. In this cross-sectional study, 160 patients with depressive disorders (13–75 years) underwent assessments for symptoms (SDS/SAS) and cognition (raw CMMS or MoCA total scores on their native 30-point scales). After listwise deletion for missing covariate data (< 5%), the analytic sample for primary analyses was N = 160. Peripheral immune (e.g., neutrophils) and metabolic (e.g., total cholesterol) markers were analyzed via multivariable regression and age-stratified analyses, adjusting for confounders. Participants were categorized into adolescents (< 18 years, n = 40) and adults (≥ 18 years, n = 120) for the primary subgroup analyses; three-group analyses were retained as exploratory sensitivity analyses because of the relatively small number of older adults. In the analytic sample ( N = 160), symptom severity correlated with neutrophil, monocyte, and WBC counts. Cognitive performance was inversely associated with neutrophil counts ( r =-0.29, P = 0.004) and nominally with total cholesterol ( r =-0.25, P = 0.012). In the adjusted model, demographic, clinical, hematological, and metabolic variables explained 34.1% of the variance in cognitive performance (adjusted R² = 0.341, P < 0.001). Exploratory subgroup analyses suggested that inverse associations between neutrophil counts and cognitive performance appeared somewhat stronger in adults. However, formal age group × biomarker interaction tests were not statistically significant, and these patterns should not be interpreted as evidence of effect modification. Associations between total cholesterol and cognitive performance were not statistically significant in adolescents ( r = − 0.31, P = 0.052). Subgroup sizes were limited. This exploratory cross-sectional study suggests that routinely available hematological and metabolic indicators, particularly neutrophil count and total cholesterol, may be associated with cognitive performance in patients with depressive disorders. The age-related subgroup findings should be considered exploratory and hypothesis-generating rather than confirmatory evidence of age-specific effects. Future longitudinal studies with larger age-stratified samples and specific inflammatory markers are needed to validate these observations.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: